Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27946885 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL28399349 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL27902893 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL27495278 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL18107435 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL27946913 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL7140554 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL18107374 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL28366749 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 | |
| SCHEMBL27413234 | 1.00 | DNM1 (0.52) | DNM1TSHRTHRBLMNAOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119219106-A | Liquid organic composition for extracting lithium and low-cost green preparation method thereof | 北京索特莱克科技发展有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118852244-A | Phosphonic acid group-containing gemini surfactant and preparation method thereof | 中国石油化工股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-116589350-A | Carboxylate emulsifier for cleaning liquid of flexible circuit board | 清源创新实验室 | 2023-08-15 | — | — | CN | claimed |
| CN-115746670-A | Hyperbranched quaternary ammonium salt antibacterial epoxy resin and preparation method thereof | 浙江工业大学 | 2023-03-07 | — | — | CN | claimed |
| CN-114456707-A | Quaternary ammonium salt antibacterial composite silicone rubber and synthesis method thereof | 浙江工业大学 | 2022-05-10 | — | — | CN | claimed |
| CN-113057934-A | Vaginal suppository and preparation method thereof | 济南亿君生医药服务有限公司 | 2021-07-02 | — | — | CN | claimed |
| CN-119219106-A | Liquid organic composition for extracting lithium and low-cost green preparation method thereof | 北京索特莱克科技发展有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-118852244-A | Phosphonic acid group-containing gemini surfactant and preparation method thereof | 中国石油化工股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-116063345-B | Phosphonic acid group monomer and preparation method thereof | 中国石油化工股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-113174413-B | Method for synthesizing polybutyl lactam by enzyme catalysis | 华东理工大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-116063626-B | Anti-calcium shrinkage and expansion agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117965890-A | Composite extraction system and application thereof in lithium ion extraction separation | 北京索特莱克科技发展有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-116064016-B | Scale inhibition anti-swelling shrinkage swelling agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20160289355-A1 | POLYMERS FUNCTIONALIZED WITH ACTIVATED NITROGEN HETEROCYCLES CONTAINING A PENDANT FUNCTIONAL GROUP | BRIDGESTONE CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| US-9266196-B2 | Ag ball, ag core ball, flux-coated ag ball, flux-coated ag core ball, solder joint, formed solder, solder paste and ag paste | SENJU METAL INDUSTRY CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-9169280-B2 | Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof | PHENOMENOME DISCOVERIES INC. (CA) | 2015-10-27 | — | — | US | disclosed |
| EP-2905349-A2 | Ag ball, Ag core ball, flux-coated Ag ball, flux-coated Ag core ball, solder joint, formed solder, solder paste and Ag paste | SENJU METAL INDUSTRY CO., LTD. (JP) | 2015-08-12 | — | — | EP | disclosed |
| US-20150217409-A1 | Ag BALL, Ag CORE BALL, FLUX-COATED Ag BALL, FLUX-COATED Ag CORE BALL, SOLDER JOINT, FORMED SOLDER, SOLDER PASTE AND Ag PASTE | Senju Metal lndustry Co., Ltd. (JP) | 2015-08-06 | — | — | US | disclosed |
| US-20140296187-A1 | METHODS FOR THE SYNTHESIS OF PLASMALOGENS AND PLASMALOGEN DERIVATIVES, AND THERAPEUTIC USES THEREOF | MED-LIFE DISCOVERIES LP (CA) | 2014-10-02 | — | — | US | disclosed |
| WO-2013071418-A1 | METHODS FOR THE SYNTHESIS OF PLASMALOGENS AND PLASMALOGEN DERIVATIVES, AND THERAPEUTIC USES THEREOF | PHENOMENOME DISCOVERIES INC. (CA) | 2013-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296187-A1 | METHODS FOR THE SYNTHESIS OF PLASMALOGENS AND PLASMALOGEN DERIVATIVES, AND THERAPEUTIC USES THEREOF | FASN, SGMS2, ALOX12 | DNM1 1132/4885TSHR 1896/4885THRB 2807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.